Latest Breaking News On - Christophe benoist - Page 4 : comparemela.com

Share this article Share this article EMERYVILLE, Calif., April 13, 2021 /PRNewswire/ Kyverna Therapeutics ( Kyverna ), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced the appointment of James Chung, M.D., Ph.D., as the Company s first Chief Medical Officer. Dr. Chung brings extensive biopharmaceutical industry experience working across the entire drug development process focused on autoimmune diseases and has dedicated a significant part of his career working in translational medicine and early clinical development. By leading the Company s Clinical Development organization, he will contribute to Kyverna s transition to a clinical-stage company. James Chung, M.D., Ph.D., Chief Medical Officer, Kyverna Therapeutics

Ignacio sanzEugenec butcherChristophe benoistGlobal medical organizationDivision of rheumatologyGlobal development leader for enbrelEmory universityGlobal developmentLowance centerEarly development inflammation therapeutic area headHarvard medical schoolSciences early developmentClinical sciences at pfizerBiology at harvard collegeUniversity of pennsylvaniaAmgen global medical organization